Chemman Labs
(ERIS BIONXT PRIVATE LIMITED)
Founded in 2020
About Chemman Labs
Wyzon Biotics Pvt. Ltd. is a leading pharmaceutical company specializing in the production of bio-pharma products, specifically focusing on human insulin manufacturing. Their goal is to establish themselves as the largest manufacturer of human insulin in Asia. By leveraging innovative techniques and technology, Wyzon aims to enhance sales, reduce costs, and strengthen theirs market position.
Key Founders and Directors of Chemman Labs
Public Links of Chemman Labs
Frequently Asked Questions (FAQ)
When was Chemman Labs founded?
Chemman Labs was founded in the year 2020.
What is the legal name of Chemman Labs?
The legal name of Chemman Labs is Eris Bionxt Private Limited.
Who are the founders of Chemman Labs?
Chemman Labs is founded by Darbar Singh Rajput, Narendra Rawtani and Surender Narain Singh.
What are the focus areas of Chemman Labs?
Who are Chemman Labs's competitors?
Possible competitors of Chemman Labs may include Ace Lifecare Llp, Asolution Pharmaceuticals Private Limited, Chemxlnc Pharma Pvt Ltd and 7 others.
Get Access to Complete Information
Signup NowYNOS is not associated with any of the entities (organisations / people) mentioned in this page. Information provided here has been curated from multiple public as well as proprietary sources. All efforts have been taken to make it accurate and complete. If details are insufficient or not accurate, kindly suggest edits
Get more information with Incubators
The Ultimate Platform for Finding the Right Incubator and Accelerator.
Get more information with Insight
The most powerful dashboard solution on Indian Startups & Investors.
Try StartupGPT, an AI-Assistant for Founders & Investors
Your conversational companion for Indian Startups, Funding, and much more.
Get more information with Govt. Funding
Discover & analyse the best government funding avenues for your startup in India.
Get more information with Debt Funding
Discover Top Loan & Debt Funding Schemes for Startups in India.
- slide 1 of 8, currently active
- slide 2 of 8
- slide 3 of 8
- slide 4 of 8
- slide 5 of 8
- slide 6 of 8
- slide 7 of 8
- slide 8 of 8
